Jazz Pharmaceuticals (JAZZ) said late Thursday it has appointed Thomas Riga as chief business officer, effective Jan. 1.
Riga joined Jazz in April 2025 following the company's acquisition of Chimerix, where he served as chief operating and commercial officer, the company said.